Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 USD | -3.04% | -31.32% | +73.31% |
05-08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
535M | - | - | ||||
111B | ||||||
105B | ||||||
22.34B | - | |||||
21.93B | - | |||||
18.59B |